Beijing Chest Hospital, Capital Medical University, Beijing, China.
Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
JAMA Netw Open. 2021 Apr 1;4(4):e215302. doi: 10.1001/jamanetworkopen.2021.5302.
The World Health Organization End TB (Tuberculosis) Strategy aims to decrease the global incidence and mortality of TB by 90% and 95%, respectively, as of 2035.
To characterize the recent epidemiological trend of pulmonary TB (PTB) in mainland China based on the national surveillance data.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study collected demographic and clinical data of all patients reported in the national Tuberculosis Information Management System of China from January 1, 2005, to November 21, 2016. Data were analyzed from December 1, 2019, to July 31, 2020.
Pulmonary TB was defined as bacteriologically confirmed or clinically diagnosed TB in the lung parenchyma or the tracheobronchial tree.
Temporal and spatial variation of annual incidence and demographic features of PTB in mainland China.
In total, 10 582 903 patients with PTB were reported in mainland China from 2005 to 2016. The median age of patients with PTB was 46 (interquartile range [IQR], 30-61) years, and 28.53% were 60 years or older. Most patients with PTB were male (69.8%) and farmers or herders (70.0%). The mean (SD) incidence of PTB was 66.61 (8.09) per 100 000 population. The annual incidence decreased from 72.95 per 100 000 population in 2005 to 52.18 per 100 000 population in 2016, and the reduction was greater in the eastern and central regions (31.6%; from 69.43 to 47.48 per 100 000 population) than in the western region (21.0%; from 82.06 to 64.82 per 100 000 population). Xinjiang Uygur Autonomous Region (135.03 per 100 000 population), Guizhou Province (115.98 per 100 000 population), and the Tibet Autonomous Region (101.98 per 100 000 population) had the highest mean annual incidences. The median time from onset of illness to diagnosis decreased from 36 (IQR, 16-92) days from 2005 to 2007 to 31 (IQR, 15-63) days in 2008 and later (P < .001) and was longer in the western region than in the eastern and central regions (41 [IQR, 20-91] vs 30 [IQR, 13-61] days; P < .001).
Although this study found that the incidence of PTB in mainland China showed a downward trend from 2005 to 2016, to achieve the World Health Organization 2035 goal, innovative and more efficient prevention and control strategies are needed, particularly among the most susceptible population, that is, farmers and herders in western China.
世界卫生组织终止结核病(TB)战略的目标是到 2035 年,将全球结核病发病率和死亡率分别降低 90%和 95%。
基于国家监测数据,描述中国大陆地区肺结核(PTB)的近期流行趋势。
设计、地点和参与者:本横断面研究收集了 2005 年 1 月 1 日至 2016 年 11 月 21 日期间中国国家结核病信息管理系统报告的所有患者的人口统计学和临床数据。数据于 2019 年 12 月 1 日至 2020 年 7 月 31 日进行分析。
肺结核定义为肺部实质或气管支气管树中经细菌学证实或临床诊断的结核。
中国大陆地区肺结核发病率的时间和空间变化以及人口统计学特征。
2005 年至 2016 年期间,中国大陆共报告了 1058.29 万例肺结核患者。肺结核患者的中位年龄为 46 岁(四分位距[IQR],30-61),60 岁及以上患者占 28.53%。大多数肺结核患者为男性(69.8%)和农民或牧民(70.0%)。肺结核的平均(SD)发病率为 66.61(8.09)/100000 人。发病率从 2005 年的 72.95/100000 人降至 2016 年的 52.18/100000 人,东部和中部地区的下降幅度更大(31.6%;从 69.43 降至 47.48/100000 人),而西部地区的下降幅度较小(21.0%;从 82.06 降至 64.82/100000 人)。新疆维吾尔自治区(135.03/100000 人)、贵州省(115.98/100000 人)和西藏自治区(101.98/100000 人)的年平均发病率最高。从发病到确诊的中位时间从 2005 年至 2007 年的 36(IQR,16-92)天缩短至 2008 年及以后的 31(IQR,15-63)天(P<0.001),且西部地区的中位时间长于东部和中部地区(41[IQR,20-91]vs 30[IQR,13-61]天;P<0.001)。
尽管本研究发现,2005 年至 2016 年期间中国大陆地区肺结核发病率呈下降趋势,但要实现世界卫生组织 2035 年的目标,仍需要创新和更有效的预防和控制策略,特别是针对最易感人群,即中国西部的农民和牧民。